389 related articles for article (PubMed ID: 21345946)
1. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.
Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L
J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946
[TBL] [Abstract][Full Text] [Related]
2. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
3. Conformation-dependent high-affinity monoclonal antibodies to prion proteins.
Stanker LH; Serban AV; Cleveland E; Hnasko R; Lemus A; Safar J; DeArmond SJ; Prusiner SB
J Immunol; 2010 Jul; 185(1):729-37. PubMed ID: 20530267
[TBL] [Abstract][Full Text] [Related]
4. A novel anti-prion protein monoclonal antibody and its single-chain fragment variable derivative with ability to inhibit abnormal prion protein accumulation in cultured cells.
Shimizu Y; Kaku-Ushiki Y; Iwamaru Y; Muramoto T; Kitamoto T; Yokoyama T; Mohri S; Tagawa Y
Microbiol Immunol; 2010 Feb; 54(2):112-21. PubMed ID: 20377745
[TBL] [Abstract][Full Text] [Related]
5. Generation of antibodies against prion protein by scrapie-infected cell immunization of PrP(0/0) mice.
Nakamura N; Miyamoto K; Shimokawa M; Nishida N; Mohri S; Kitamoto T; Horiuchi H; Furusawa S; Matsuda H
Hybrid Hybridomics; 2003 Aug; 22(4):263-6. PubMed ID: 14511572
[TBL] [Abstract][Full Text] [Related]
6. Vaccine approaches to prevent and treat prion infection : progress and challenges.
Müller-Schiffmann A; Korth C
BioDrugs; 2008; 22(1):45-52. PubMed ID: 18215090
[TBL] [Abstract][Full Text] [Related]
7. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
8. Induction of antibodies against murine full-length prion protein in wild-type mice.
Koller MF; Grau T; Christen P
J Neuroimmunol; 2002 Nov; 132(1-2):113-6. PubMed ID: 12417440
[TBL] [Abstract][Full Text] [Related]
9. Generation of antisera to purified prions in lipid rafts.
Hnasko R; Serban AV; Carlson G; Prusiner SB; Stanker LH
Prion; 2010; 4(2):94-104. PubMed ID: 20647769
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
[TBL] [Abstract][Full Text] [Related]
11. Development of antibody fragments for immunotherapy of prion diseases.
Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
[TBL] [Abstract][Full Text] [Related]
12. Anti-prion antibodies for prophylaxis following prion exposure in mice.
Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of abnormal prion protein (PrP(Sc)) in murine scrapie prions determined by PrP(Sc)-specific monoclonal antibodies.
Ushiki-Kaku Y; Shimizu Y; Tabeta N; Iwamaru Y; Ogawa-Goto K; Hattori S; Yokoyama T
J Vet Med Sci; 2014 Mar; 76(2):285-8. PubMed ID: 24132297
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
Prusiner SB
Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.
Handisurya A; Gilch S; Winter D; Shafti-Keramat S; Maurer D; Schätzl HM; Kirnbauer R
FEBS J; 2007 Apr; 274(7):1747-58. PubMed ID: 17313482
[TBL] [Abstract][Full Text] [Related]
18. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.
Nikles D; Bach P; Boller K; Merten CA; Montrasio F; Heppner FL; Aguzzi A; Cichutek K; Kalinke U; Buchholz CJ
J Virol; 2005 Apr; 79(7):4033-42. PubMed ID: 15767405
[TBL] [Abstract][Full Text] [Related]
19. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
[TBL] [Abstract][Full Text] [Related]
20. Tracing conformational transition of abnormal prion proteins during interspecies transmission by using novel antibodies.
Ushiki-Kaku Y; Endo R; Iwamaru Y; Shimizu Y; Imamura M; Masujin K; Yamamoto T; Hattori S; Itohara S; Irie S; Yokoyama T
J Biol Chem; 2010 Apr; 285(16):11931-6. PubMed ID: 20177064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
